CANTON, Conn., Nov. 11, 2024 /PRNewswire/ — Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for the third quarter ended September 30, 2024. “Kelyniam has consistently delivered strong performance year on year,” said Ross Bjella, CEO of Kelyniam….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.